Loading...

Joinn Laboratories(China)Co.,Ltd.

6127.HKHKSE
Healthcare
Medical - Diagnostics & Research
HK$16.68
HK$0.54(3.35%)

Joinn Laboratories(China)Co.,Ltd. (6127.HK) Company Profile & Overview

Explore Joinn Laboratories(China)Co.,Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Joinn Laboratories(China)Co.,Ltd. (6127.HK) Company Profile & Overview

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEODr. Yuxia Feng M.D.

Contact Information

86 10 6786 9966
A5 Rongjing East Street, Beijing, 100176

Company Facts

2,510 Employees
IPO DateFeb 26, 2021
CountryCN
Actively Trading

Frequently Asked Questions